Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 11 studies | 31% ± 11% | |
epithelial cell | 4 studies | 17% ± 1% | |
endothelial cell | 3 studies | 21% ± 5% | |
GABAergic neuron | 3 studies | 27% ± 3% | |
glutamatergic neuron | 3 studies | 34% ± 4% | |
oligodendrocyte precursor cell | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 34% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 993.01 | 1445 / 1445 | 100% | 14.13 | 183 / 183 |
lung | 100% | 1440.84 | 577 / 578 | 100% | 12.01 | 1153 / 1155 |
brain | 100% | 1328.49 | 2629 / 2642 | 100% | 15.07 | 703 / 705 |
breast | 100% | 1240.12 | 459 / 459 | 99% | 12.91 | 1108 / 1118 |
ovary | 100% | 1034.61 | 180 / 180 | 99% | 8.34 | 426 / 430 |
thymus | 100% | 1382.24 | 653 / 653 | 99% | 14.59 | 598 / 605 |
intestine | 100% | 877.33 | 966 / 966 | 99% | 10.44 | 520 / 527 |
bladder | 100% | 968.86 | 21 / 21 | 99% | 10.02 | 497 / 504 |
stomach | 99% | 718.61 | 355 / 359 | 99% | 12.15 | 283 / 286 |
uterus | 100% | 1082.59 | 170 / 170 | 98% | 11.42 | 449 / 459 |
kidney | 100% | 720.81 | 89 / 89 | 97% | 10.03 | 875 / 901 |
skin | 100% | 1693.38 | 1806 / 1809 | 97% | 18.96 | 457 / 472 |
prostate | 100% | 757.76 | 244 / 245 | 97% | 8.93 | 487 / 502 |
adrenal gland | 99% | 859.18 | 256 / 258 | 96% | 8.25 | 221 / 230 |
pancreas | 93% | 564.83 | 306 / 328 | 99% | 9.42 | 177 / 178 |
liver | 92% | 472.59 | 209 / 226 | 92% | 5.86 | 373 / 406 |
spleen | 100% | 1382.42 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 1429.87 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1083.40 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1904.21 | 911 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 11.11 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 97% | 10.09 | 28 / 29 |
heart | 90% | 441.32 | 771 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 6.27 | 62 / 80 |
muscle | 60% | 199.88 | 485 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051260 | Biological process | protein homooligomerization |
GO_0090026 | Biological process | positive regulation of monocyte chemotaxis |
GO_0140042 | Biological process | lipid droplet formation |
GO_0006935 | Biological process | chemotaxis |
GO_0090023 | Biological process | positive regulation of neutrophil chemotaxis |
GO_0140284 | Cellular component | endoplasmic reticulum-endosome membrane contact site |
GO_0012505 | Cellular component | endomembrane system |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0035579 | Cellular component | specific granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0044232 | Cellular component | organelle membrane contact site |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0033149 | Molecular function | FFAT motif binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MOSPD2 |
Protein name | Motile sperm domain containing 2 Motile sperm domain-containing protein 2 |
Synonyms | hCG_15755 |
Description | FUNCTION: Endoplasmic reticulum-anchored protein that mediates the formation of contact sites between the endoplasmic (ER) and endosomes, mitochondria or Golgi through interaction with conventional- and phosphorylated-FFAT-containing organelle-bound proteins . In addition, forms endoplasmic reticulum (ER)-lipid droplets (LDs) contacts through a direct protein-membrane interaction and participates in LDs homeostasis . The attachment mechanism involves an amphipathic helix that has an affinity for lipid packing defects present at the surface of LDs . Promotes migration of primary monocytes and neutrophils, in response to various chemokines . . |
Accessions | ENST00000497603.2 Q8NHP6 R4GMW5 ENST00000482354.5 ENST00000380492.8 [Q8NHP6-1] R4GNB6 R4GMN1 ENST00000460386.1 |